Henan Lingrui Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 909.05 million compared to CNY 788.65 million a year ago. Revenue was CNY 909.05 million compared to CNY 788.65 million a year ago.

Net income was CNY 190.38 million compared to CNY 144.25 million a year ago. Basic earnings per share from continuing operations was CNY 0.34 compared to CNY 0.26 a year ago. Diluted earnings per share from continuing operations was CNY 0.336 compared to CNY 0.254 a year ago.